The underwriting performance of Central Reinsurance Corporation's (Central Re) domestic non-life portfolio deteriorated in 2022, mainly driven by a significant COVID-19 pandemic insurance loss, while its domestic life business continued to deliver a solid stream of earnings, says AM Best.